Page 14 - Demo

12 Corporate GovernanceMarco Gadola, Chairman(1963, Swiss)Marco Gadola has been a member of the Board of Directors of DKSH since January 1, 2020, and Chairman of the Board of Directors since May 2020. He was CEO of the Straumann Group from 2013 until the end of 2019. Previously, he was the Regional CEO of Asia Pacific at Panalpina from 2012 to 2013 and CFO of Panalpina from 2008 to 2012. From 2006 to 2008, he was CFO of Straumann. Before joining Straumann for the first time in 2006, he was CFO of Hero from 2001 to 2006 and before that, worked for Hilti, Sandoz International Ltd., and Swiss Bank Corporation. Marco Gadola is Chairman of the Board of Directors of WS Audiology and Medartis Holding AG, Vice Chairman of the Board of Directors of MCH Group AG, as well as a member of the Board of Directors of Straumann Holding AG, AVAG Anlage und Verwaltungs AG, and B%u00fchler Holding AG. He is also a member of the Standortf%u00f6rderungskommission Baselland. Marco Gadola holds a degree in Business Administration and Economics from Basel University, Switzerland, and has completed various programs at the London School of Economics, UK, INSEAD, France, and IMD, Switzerland. Gabriel Baertschi(1974, Swiss)Gabriel Baertschi has been a member of the Board of Directors of DKSH since March 2023 and is currently a member of the Nomination and Compensation Committee and the Mergers and Acquisitions Committee. He is CEO and Chairman of the Corporate Executive Board of Gr%u00fcnenthal GmbH. Prior to taking the position at Gr%u00fcnenthal, he worked for the AstraZeneca Group as Company President of Japan (2013 to 2016), as Company President of Germany (2010 to 2012), as Company President of Thailand (2009 to 2010), and as General Manager of Vietnam and Indochina (2006 to 2009). Prior to his appointment to the Executive Committee, Gabriel Baertschi held various strategic roles in international sales and marketing with the AstraZeneca Group. Gabriel Baertschi is a member of the Board of Directors of MedXCell SA, a Swiss-French biotech company focused on cell therapy, and RealizedCare, a digital care start-up company based in the USA. Gabriel Baertschi holds a Master of Science in Biology from the University of Neuch%u00e2tel, Switzerland. He also successfully completed the program %u201cLeading Enterprise Transformation%u201d at Harvard Business School, USA.